Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer

Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer

OBJECTIVE: Patients with recurrent triple-negative breast cancer (TNBC) currently have no established treatment option other than chemotherapy. However, long-term chemotherapy is often difficult due to adverse effects. A previous study documented a 10%–30% response rate of progestins in oestrog...

Full description

Bibliographic Details
Main Authors: Xiangying Meng, Shikai Wu, Zefei Jiang, Bing Sun, Yan Ma, Xin Zhao, Lijuan Ding, Yue Wang, Tao Wang, Shaohua Zhang, Santai Song
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2013-05-01
Series:Swiss Medical Weekly
Subjects:
medroxyprogesterone acetate
megestrol acetate
recurrent breast cancer
triple-negative breast cancer
Online Access:https://www.smw.ch/index.php/smw/article/view/1696

Internet

https://www.smw.ch/index.php/smw/article/view/1696

Similar Items